View in EDS HTML Full Text PDF Full Text

Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.

Saved in:
Bibliographic Details
Title: Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
Authors: El-Mahdy NA; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt., El-Sayad ME; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt., El-Kadem AH; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt., Abu-Risha SE; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt.
Source: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2021 Feb; Vol. 35 (1), pp. 143-155. Date of Electronic Publication: 2020 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-8206 (Electronic) Linking ISSN: 07673981 NLM ISO Abbreviation: Fundam Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32383169
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22El-Mahdy+NA%22">El-Mahdy NA</searchLink>; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt.<br /><searchLink fieldCode="AU" term="%22El-Sayad+ME%22">El-Sayad ME</searchLink>; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt.<br /><searchLink fieldCode="AU" term="%22El-Kadem+AH%22">El-Kadem AH</searchLink>; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt.<br /><searchLink fieldCode="AU" term="%22Abu-Risha+SE%22">Abu-Risha SE</searchLink>; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Tanta University, Tanta, 31527, Egypt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228710411%22">Fundamental & clinical pharmacology</searchLink> [Fundam Clin Pharmacol] 2021 Feb; Vol. 35 (1), pp. 143-155. <i>Date of Electronic Publication: </i>2020 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8710411 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-8206 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207673981%22">07673981 </searchLink><i>NLM ISO Abbreviation: </i>Fundam Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32383169
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/fcp.12563
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 143
    Titles:
      – TitleFull: Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: El-Mahdy NA
      – PersonEntity:
          Name:
            NameFull: El-Sayad ME
      – PersonEntity:
          Name:
            NameFull: El-Kadem AH
      – PersonEntity:
          Name:
            NameFull: Abu-Risha SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2021 Feb
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1472-8206
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Fundamental & clinical pharmacology
              Type: main
ResultId 1